4710
Cholestatic liver disease with ductopenia ( vanishing bile duct syndrome ) after administration of clindamycin and trimethoprim - sulfamethoxazole .
 adverse effect: Cholestatic liver disease, clindamycin; adverse effect: Cholestatic liver disease, trimethoprim - sulfamethoxazole; adverse effect: ductopenia, clindamycin; adverse effect: ductopenia, trimethoprim - sulfamethoxazole; adverse effect: vanishing bile duct syndrome, clindamycin; adverse effect: vanishing bile duct syndrome, trimethoprim - sulfamethoxazole
Given options, please tell me the relationships of all the listed entity pairs.Output format is "relation1: word1, word2; relation2: word3, word4". 
Option: adverse effect 
Text: {0} 
 Entity Pairs:  Cholestatic liver disease, clindamycin; Cholestatic liver disease, trimethoprim - sulfamethoxazole; ductopenia, clindamycin; ductopenia, trimethoprim - sulfamethoxazole; vanishing bile duct syndrome, clindamycin; vanishing bile duct syndrome, trimethoprim - sulfamethoxazole 
Answer:
 adverse effect: Cholestatic liver disease, clindamycin; adverse effect: Cholestatic liver disease, trimethoprim - sulfamethoxazole; adverse effect: ductopenia, clindamycin; adverse effect: ductopenia, trimethoprim - sulfamethoxazole; adverse effect: vanishing bile duct syndrome, clindamycin; adverse effect: vanishing bile duct syndrome, trimethoprim - sulfamethoxazole